Context Therapeutics’ $28.75 Million IPO

Troutman Pepper Hamilton Sanders advised Context Therapeutics Inc. on the deal.Context Therapeutics Inc., a women’s oncology company developing advanced small molecule and immunotherapy treatments to transform…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here